In Vitro Metabolism Studies

In recent years, the field of in vitro metabolism studies has gained prominence, offering a controlled and efficient approach to investigating drug metabolism. With a team of highly skilled scientists and a diverse therapy development platform, our company proudly provides state-of-the-art in vitro metabolism research services to meet any needs of the global pharmaceutical industry in autoimmune disease and inflammation research.

Overview of In Vitro Metabolism Study

In vitro metabolism studies encompass the investigation of drug metabolism utilizing isolated biological systems, such as liver microsomes, hepatocytes, or recombinant enzyme systems. By replicating the physiological conditions of drug metabolism in a controlled environment outside of the human body, in vitro studies offer researchers a holistic comprehension of drug fate and potential interactions with metabolizing enzymes. Through these studies, valuable insights can be gained, including the identification of metabolites, evaluation of metabolic stability, determination of metabolic pathways, and assessment of drug-drug interactions. This enables researchers to make informed decisions regarding drug development and optimization.

4-4-2-1-2-in-vitro-metabolism-studies-1Fig. 1 Protocol for in vitro metabolic studies. (Choi S., et al., 2022)

In Vitro Metabolism Study for Autoimmune Diseases and Inflammation

Unveiling the Molecular Mechanisms

In vitro metabolism studies provide insights into the molecular mechanisms underlying autoimmune diseases. By studying the metabolism of drugs and their interaction with metabolizing enzymes in the context of autoimmune diseases, researchers can identify potential biomarkers and therapeutic targets. These findings could help in the development of personalized therapies.

Evaluating Drug Efficacy and Safety

In vitro metabolism studies play a crucial role in assessing the efficacy and safety of potential drug candidates for autoimmune diseases and inflammation. By investigating the metabolism of drugs in a controlled environment, researchers can identify potential metabolic liabilities and predict how a drug may be processed within the body. This knowledge aids in the selection and optimization of drug candidates, promoting successful therapeutic development.

Unraveling Drug-Drug Interactions

Autoimmune diseases often require multiple medications to control. In vitro metabolism studies enable researchers to evaluate potential drug-drug interactions by examining how different drugs may affect each other's metabolism. This information helps in the design of treatment regimens that minimize adverse interactions and maximize therapeutic efficacy.

Our Services

In the context of autoimmune diseases and inflammation, in vitro metabolism studies offer a deeper understanding of the molecular mechanisms, facilitate the evaluation of drug candidates, and unravel potential drug-drug interactions. Our company's exceptional in vitro metabolism studies services provide researchers with reliable data and support to advance their research in these areas.

Reaction Phenotyping Cytochrome P450 Studies
  • Phenotyping of metabolizing enzymes
  • Non-CYP mediated metabolism
  • Extrahepatic Metabolism
  • CYP450 induction
  • CYP450 reaction phenotyping
  • CYP450 inhibition and time-dependent inhibition
Metabolic Stability Metabolite Identification and Profiling
  • In vitro metabolism in liver microsomes / rCYPs / hepatocytes / S-9 fraction
  • Half-life, in vitro clearance
  • In vivo extrapolation (hepatic clearance / extraction ratio)
  • Matrix stability in SGF/SIF, plasma, tissue, etc.
  • Identification of hepatocytes, liver microsomes, S9, extrahepatic tissues, or recombinant enzymes
  • Identification and profiling of small molecule drugs, peptides drugs, and antibody drug

Why Choose Us?

High Data Quality

High Data Quality

Professional Team

Professional Team

One-stop Platform

One-stop Platform

Cost and Efficiency

Cost and Efficiency

Our company's in vitro metabolism studies services offer numerous advantages that contribute to the advancement of autoimmune disease and inflammation research. If you are interested in our services, please don't hesitate to contact us.

Reference

  1. Marques, Cátia F., Pedro F. Pinheiro, and Gonçalo C. Justino. "Protocol to study in vitro drug metabolism and identify montelukast metabolites from purified enzymes and primary cell cultures by mass spectrometry." STAR protocols 4.1 (2023): 102086.
For research use only. Not intended for any clinical use.